Lyka, a Sydney-based provider of fresh, gently cooked human-grade dog food via subscription, has raised $67M in Series C funding led by LGVP. Veterinary nutritionists formulate the meals using Australian-sourced ingredients to address issues like allergies, digestion, and obesity. The capital will fund global expansion, new products, clinical trials on canine longevity, and manufacturing scale-up.
Premium Segment Grows Amid PFAS Scare
The raise aligns with rising concerns over contaminants in conventional pet food. A February 2026 study found higher PFAS levels in wet pet foods, spotlighting risks in processed kibble. Australia's pet food market stands at $3.91B in 2025, projected to reach $5.24B by 2031 at 5% CAGR. Lyka's clean, fresh approach positions it ahead of kibble-dominant rivals.
Kibble Overlooked by 70% of Owners
Seven out of 10 Australian dog owners ignore stool quality as a health indicator, per Lyka's national survey. Meanwhile, 94% recognize processed foods as unhealthy, yet 87% view kibble as nutritious. This disconnect fuels demand for real-food alternatives, as 96% of Lyka customers report dog health improvements. Conventional dry foods fail to deliver on digestion, skin, and weight management.
Vet-Formulated Meals Retain Nutrients
Lyka gently cooks meals below 90°C to preserve nutrients, unlike high-heat kibble processing. Recipes feature novel proteins like kangaroo and goat for hypoallergenic needs, personalized via algorithms. Carbon-negative production uses 85-95% local ingredients. This contrasts with competitors like Raw & Fresh, which focuses on raw BARF diets without vet personalization.
Personalization Beats Freeze-Dried Rivals
FurFresh offers freeze-dried meals for shelf life, but Lyka prioritizes fresh-frozen delivery for peak nutrition. Doggy Grub and LilFood mimic slow-cooked formats yet lack Lyka's scale and 1,100+ vet endorsements. Lyka has served 65M+ bowls to 100,000+ dogs, achieving $200M ARR.
As Lyka Co-Founder & Head of Product Dr. Matthew J. Muir noted:
"Our recipes are designed for wholefood nutrition and preventative pet medicine."
US VC Signals Global Ambitions
New York-based LGVP led the round, bringing total funding to $155M after $55M Series B in 2023. Airtree Ventures and Petbarn founder participated. This US entry validates Lyka's vertical integration, including a $16M Dandenong factory opened in 2024. Investor focus on longevity research underscores shift from pet food to pet health tech.
Fresh Segment Claims 10% Share
Australia's $21.3B annual pet spend allocates half to food, with premium fresh/raw rising from 1-3% to 10% market share. Mordor Intelligence forecasts steady 5% overall growth, but humanization accelerates DTC subscriptions. Bootstrapped rivals like Raw & Fresh and FurFresh trail Lyka's funded scale.
Pet Owners Fuel $4B+ Expansion
Post-COVID pet ownership boom sustains premiumization despite cost pressures. Lyka's B Corp status and sustainability edge differentiate in a market favoring ethical sourcing. No major competitor fundings reported recently, highlighting Lyka's lead.
Ex-Bain Vet Duo Drives Scale
Founder & CEO Anna Podolsky, ex-Bain & Company consultant with math expertise, pairs with Co-Founder Dr. Matthew J. Muir, an integrative vet with 15+ years. Recent hires include CMO Cameron Luby (ex-Google, Optus) and Head of Manufacturing Andy Baxter (ex-CSL). This team grew from 201-500 to 400-strong, backing 97%+ customer satisfaction.
Clinical Trials Eye Longevity
Lyka plans university partnerships with Sydney, Queensland, and Massey NZ for health trials. The $16M hub supports new products and international markets. With 100M+ meals served, focus shifts to evidence-based longevity claims.